CRISPR Therapeutics AG - CRSP
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G/A | ORBIS INVESTMENT MANAGEMENT LTD | 6.2% | 5,934,328 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Allan Gray Australia Pty Ltd | 0.0% | 15,817 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Capital International Investors | 1.2% | 1,186,794 | View |
| Nov 14, 2025 | SCHEDULE 13G | ORBIS INVESTMENT MANAGEMENT LTD | 5.5% | 4,974,125 | View |
| Nov 14, 2025 | SCHEDULE 13G | Allan Gray Australia Pty Ltd | 0.0% | 7,960 | View |
| Nov 04, 2025 | SCHEDULE 13G/A | ARK Investment Management LLC | 10.76% | 9,786,973 | View |
| Nov 04, 2025 | SCHEDULE 13G/A | Catherine D. Wood | 10.76% | 9,786,973 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.